# FDA WARNING_LETTER - Intas Pharmaceuticals Limited - May 12, 2023

Source: https://www.globalkeysolutions.net/records/warning_letter/intas-pharmaceuticals-limited/9e0758c3-e43d-4af6-8f19-a85862cedff3

> FDA WARNING_LETTER for Intas Pharmaceuticals Limited on May 12, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2023-05-12
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [WARNING_LETTER - 2022-12-02](https://www.globalkeysolutions.net/records/warning_letter/intas-pharmaceuticals-limited/69e72c80-0677-41df-92b7-50c9a9d7402e)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)

Company: https://www.globalkeysolutions.net/companies/intas-pharmaceuticals-limited/cfedbb2f-5587-42dc-985b-044083dd01e5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c